Diabetes drug pioglitazone (Actos): risk of fracture
2007
Reason for posting: Pioglitazone is an oral hypoglycemic agent widely used as monotherapy or combination therapy for type 2 diabetes mellitus. However, a recent analysis by the drug's manufacturer of several unpublished clinical trials in the company's database revealed an increased risk of bone
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
2
References
43
Citations
NaN
KQI